DEFINITIVE CONTRACT
Active75F40126C00087
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$1.2M
obligated · signed 2 weeks ago
FDA BAA FY26C1CP13 3-YEAR FIRM-FIXED PRICE (FFP) CONTRACT FOR INVESTIGATING THE IMPACT OF DIASTEREOMERS AND SYNTHESIS-RELATED IMPURITIES ON THE IMMUNOGENICITY OF OLIGONUCLEOTIDES.
Performance timeline
Start
Sep 30, 2026
Current end
Sep 29, 2027
Potential end
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
UNIVERSITY OF CONNECTICUT
Contract 75F40126C00087
UEI
WNTPS995QBM7
Parent Company
UNIVERSITY OF CONNECTICUT
Capabilities & Certifications
Headquarters Location
Congressional District: 02
Current Obligation
$1,173,033
Base + Exercised Options
$1,173,033
Total Ceiling Value
$2,432,643
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 02
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.